INTEGRATED SOLUTIONS GROUP for TEVA PHARMACEUTICALS USA
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 20, 2011 | $50,000 | Replaced |
| 1st Quarter - Amendment | Apr 20, 2011 | $50,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
H.R. 1432 - Patent Settlements; H.R. 1695 - Generic Biologics; H.R. 5629 - Physician Payment Sunshine Act; S.2029 - Patent Reform; H.R. 1908 - Import Safety Act; H.R. 3100 - Affordable Health Choices Act S.515 - Patent Reform Act Financial services and general appropriations bill - 2010 S.A. 4727 - The Middle Class Tax Cut Act 2010
| Lobbyist | Covered position, as disclosed |
|---|---|
| MOSES BOYD | Counsel, Senate Commerce Committee |
| MYCHAL S BOYD | — |
| G JOHN O'HANLON | — |
| ADAM S OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.